Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymogen

Glu-Trp, EW dipeptide, Oglufanide, L-Glutamyl-L-tryptophan

Quick Stats
Studies 94
Trials 51
Score 2
1994 pubmed

[Determination of functional activity of lymphocytes in patients with tuberculosis and in patients of group IIIA of clinic registries by electrophoretic mobility].

Morozova. T I TI; Khudzik. L B LB; Tikhomirova. L A LA

Key Findings

  • TB patients and those with residual lung changes show abnormal lymphocyte functional activity
  • Thymogen (thymalin) administration improves T‑cell and B‑cell activity in these patients
  • Thymogen enhances tolerance to anti‑recurrence chemotherapy in the studied group

Practical Outcomes

  • For biohackers, thymogen may have modest immune‑support benefits, especially for people dealing with infections or undergoing chemotherapy, but the data are disease‑specific and not proven for healthy individuals seeking longevity or performance gains. Use with caution and consider the limited evidence before adding it to a general health protocol.

Summary

The study looked at how immune cells move in people with active TB, those who had been cured, and healthy volunteers. It found that both sick and previously sick people had abnormal immune cell activity, and that giving a thymus‑derived peptide called thymogen (or thymalin) helped boost T‑cell and B‑cell function and made patients tolerate follow‑up chemotherapy better. The results suggest thymogen can act as an immune‑boosting supplement in specific disease contexts, but the evidence is limited to TB patients and not directly about healthy longevity or performance.

Abstract

The electrophoretic mobility of peripheral blood lymphocytes was studied in 35 patients with pulmonary tuberculosis, 128 persons clinically cured of tuberculosis, and 30 healthy persons by using an Elphor-VaP-5 apparatus (Germany). This study revealed abnormal lymphocytic functional activity both in patients with tuberculosis and in patients with great residual changes after prior tuberculosis, which was the basis for using of thymic immunomodulators (thymalin or thymogen) in the latters. Immunomodulators improved the tolerance of antirecurrent chemotherapy in persons with IIIA dispensary register group and produced a marked stimulating effect on the functional activity of T and B lymphocytes.

Study Information

Provider

pubmed

Year

1994